WEBINAR RECORDING
Why Are Some PFO Programs 270% More Effective Than Others?
OBJECTIVES
Why do some PFO programs identify dramatically more treatable patients while others miss them? The difference is often not technology alone, it is workflow.
- Review clinical and real-world data demonstrating the ability to improve PFO detection and closure programs by +270 percent, or more.
- Examine the role of NG2 autonomous robotic TCD technology in delivering higher-sensitivity, standardized RLS screening, and why earlier adoption may be critical.
- Explore the broader downstream impact of increasing PFO closures, including referral efficiency, multidisciplinary alignment, program growth, and long-term patient outcomes.
If you influence stroke pathways, structural heart programs, or closure decision-making, this discussion is designed to challenge how your current workflow performs and where measurable improvement may be possible.
Speaker
Dr. Gregory Brett Walker, MD, FRCPC
Stroke and Interventional Neurologist at Royal Columbian Hospital
Stroke and Interventional Neurologist at Royal Columbian Hospital and Assistant Professor at the University of British Columbia. His work focuses on cerebrovascular disease, acute stroke intervention, and advancing neurovascular care through clinical research, structured stroke systems, and multidisciplinary program development.
Dr. Razi Khan
Interventional Cardiologist at Royal Columbian Hospital
Interventional Cardiologist at Royal Columbian Hospital. His practice centers on structural heart interventions including transcatheter PFO and ASD closure, with a focus on procedural excellence, referral pathway clarity, and collaborative stroke care delivery.